Oncogene
2004,23(39):6677–6683.PubMedCrossRef 13. Kong W, Mou X, Liu Q, Chen Z, Vanderburg CR, Rogers JT, Huang X: Independent component analysis of Alzheimer’s DNA microarray gene expression data. Mol Neurodegener 2009,4(1):5.PubMedCrossRef 14. Zhang XW, Yap YL, Wei D, Chen F, Danchin A: Molecular diagnosis of human cancer type by gene expression profiles and independent component analysis. Eur J Hum Genet 2005,13(12):1303–1311.PubMedCrossRef 15. Hyvarinen A, Oja E: Independent component analysis: algorithms and applications. Neural Netw 2000,13(4–5):411–430.PubMedCrossRef 16. Smyth GK: limma: Linear Models for Microarray MM-102 mw Data. Edited by: Gentleman R, Carey VJ, Huber W, Irizarry RA, Dudoit S. Bioinformatics and Computational Biology Solutions using R and Bioconductor NY: Springer; 2005. 17. Dasgupta T, de Kievit TR, Masoud H, Altman E, Richards JC, Sadovskaya I, Speert DP, Lam JS: Characterization of lipopolysaccharide-deficient {Selleck Anti-cancer Compound Library|Selleck Anticancer Compound Library|Selleck Anti-cancer Compound Library|Selleck Anticancer Compound Library|Selleckchem Anti-cancer Compound Library|Selleckchem Anticancer Compound Library|Selleckchem Anti-cancer Compound Library|Selleckchem Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|Anti-cancer Compound Library|Anticancer Compound Library|buy Anti-cancer Compound Library|Anti-cancer Compound Library ic50|Anti-cancer Compound Library price|Anti-cancer Compound Library cost|Anti-cancer Compound Library solubility dmso|Anti-cancer Compound Library purchase|Anti-cancer Compound Library manufacturer|Anti-cancer Compound Library research buy|Anti-cancer Compound Library order|Anti-cancer Compound Library mouse|Anti-cancer Compound Library chemical structure|Anti-cancer Compound Library mw|Anti-cancer Compound Library molecular weight|Anti-cancer Compound Library datasheet|Anti-cancer Compound Library supplier|Anti-cancer Compound Library in vitro|Anti-cancer Compound Library cell line|Anti-cancer Compound Library concentration|Anti-cancer Compound Library nmr|Anti-cancer Compound Library in vivo|Anti-cancer Compound Library clinical trial|Anti-cancer Compound Library cell assay|Anti-cancer Compound Library screening|Anti-cancer Compound Library high throughput|buy Anticancer Compound Library|Anticancer Compound Library ic50|Anticancer Compound Library price|Anticancer Compound Library cost|Anticancer Compound Library solubility dmso|Anticancer Compound Library purchase|Anticancer Compound Library manufacturer|Anticancer Compound Library research buy|Anticancer Compound Library order|Anticancer Compound Library chemical structure|Anticancer Compound Library datasheet|Anticancer Compound Library supplier|Anticancer Compound Library in vitro|Anticancer Compound Library cell line|Anticancer Compound Library concentration|Anticancer Compound Library clinical trial|Anticancer Compound Library cell assay|Anticancer Compound Library screening|Anticancer Compound Library high throughput|Anti-cancer Compound high throughput screening| mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6. Infect Immun 1994,62(3):809–817.PubMed 18. Cryz SJ Jr, Pitt TL, Furer E, Germanier R: Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa. Infect Immun 1984,44(2):508–513.PubMed 19. Engels W, Endert J, Kamps MA, van Boven CP: Role of lipopolysaccharide in opsonization and Torin 2 molecular weight phagocytosis of Pseudomonas aeruginosa. Infect Immun 1985,49(1):182–189.PubMed
20. Hancock RE, Mutharia LM, Chan L, Darveau RP, Speert DP, Pier GB: Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 1983,42(1):170–177.PubMed 21. Amiel E, Lovewell RR, O’Toole GA, Hogan DA, Berwin B: Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect Immun 2010,78(7):2937–2945.PubMedCrossRef 22. Zhang Z, Louboutin JP, Weiner DJ, Goldberg JB, Wilson JM:
Human airway epithelial cells sense Pseudomonas aeruginosa infection via recognition of flagellin by Toll-like receptor 5. Infect Immun 2005,73(11):7151–7160.PubMedCrossRef 23. Mahenthiralingam E, Speert Rebamipide DP: Nonopsonic phagocytosis of Pseudomonas aeruginosa by macrophages and polymorphonuclear leukocytes requires the presence of the bacterial flagellum. Infect Immun 1995,63(11):4519–4523.PubMed 24. Vallet I, Olson JW, Lory S, Lazdunski A, Filloux A: The chaperone/usher pathways of Pseudomonas aeruginosa: identification of fimbrial gene clusters (cup) and their involvement in biofilm formation. Proc Natl Acad Sci USA 2001,98(12):6911–6916.PubMedCrossRef 25. O’Toole GA, Kolter R: Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol 1998,30(2):295–304.PubMedCrossRef 26.